Articles

• Promising Developments in Drug Delivery

  By Robert L. Avery, MD; and Allen C. Ho, MD

FEATURE STORY

• Gene Vector Delivery Platform Targets Retinal Diseases

  The LentiVector technology delivers genes into retinal cells efficiently and stably.

  By Jennifer Kreatsoulas, PhD, News & Contributing Editor

• RETINAWS: An Instructional Course in Vitrectomy Surgery

  By Kourous A. Rezaei, MD

• Medical Udpate

  A summary of general medicine news that affects your patients, your practice, and you.

  By Section Editor: David Boyer, MD

BUSINESS OF RETINA

• The Path to Intravitreal Bevacizumab

  A logical decision based on scientific facts and clinical intuition.

  By Philip J. Rosenfeld, MD, PhD

• Applying To Vitreoretinal Surgery Fellowship

  Advice from recent candidates.

  By /with contributions from Paul Baker, MD; Leon Charkoudian, MD; Vivek Chaturvedi, MD; and Hani Salehi-Had, MD

• Opportunities and Challenges for ASCs in 2009

  Ophthalmologists will benefit by getting involved as the Medicare landscape evolves.

  By Michael Romansky

RETINA SURGERY

• Retinal Endoscopy, Illumination, and Photocoagulation

  The endoscope allows visualization and treatment of structures that would otherwise remain hidden.

  By Jorge G. Arroyo, MD, MPH; Taiga Kinoshita, MD; and Kyle D. Kovacs

• The Role of Steroids in the Treatment of Diabetic Macular Edema

  Multiple pharmacologic strategies are currently available.

  By Paolo Lanzetta, MD; and Daniele Veritti, MD

COVER STORIES

• Recent Advances in Back of the Eye Drug Delivery

  An overview of what is new in research and development.

  By Rad Tzekov MD, PhD; Mark B. Abelson MD, CM, FRCSC; and Daniel Dewey-Mattia

• Dexamethasone Implant for DME

  The Posurdex device has shown safety and efficacy in phase 2 and 2b studies to date.

  By Baruch D. Kuppermann, MD, PhD

• Pharmacokinetics of Sustained-delivery Fluocinolone Acetonide for DME

  The Iluvien retinal insert provides sustained delivery for 1 year.

  By Reviewed by Peter A. Campochiaro, MD

• Transporter-targeted Drug Delivery to the Retina

  By Sudharshan Hariharan; Nilay R. Thakkar; and Ashim K. Mitra, PhD

• Nanotechnology in Retinal Diseases

  Several promising areas under study, including drug and gene delivery.

  By Marco A. Zarbin, MD, PhD, FACS

OCULAR ONCOLOGY

• Advances in Chemotherapy for Retinoblastoma

  Super-selective intraarterial infusion has proved successful with few complications.

  By David H. Abramson, MD, FACS

RETINAL IMAGING

• Imaging for Diabetic Macular Edema

  An overview of the retina module of the Heidelberg Retina Tomograph 3.

  By Kemeni E. Tenku, BS; Malik Y. Kahook, MD; Cullen Barnett COT, CRA; Naresh Mandava, MD; and Scott C. N. Oliver, MD

BUSINESS OF RETINA

• Managing the New Logistics of Retinal Therapy

  In an ongoing series, a practitioner explains how his practice manages the increase in patient volume brought on by intravitreal injections.

  By W. Sanderson Grizzard, MD, Partner, Retina Associates of Florida

DEPARTMENTS

• Innovations

• 5 Questions With Tarek S. Hassan, MD

  Dr. Hassan is a vitreoretinal physician at Associated Retinal Consultants in Royal Oak, Michigan, and a Clinical Assistant Professor of Biomedical Sciences at Oakland University in Rochester, Michigan.

View All News >